Runben Biotechnology Co Ltd
SSE:603193
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (50.4), the stock would be worth ¥24.23 (7% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 54 | ¥25.97 |
0%
|
| 3-Year Average | 50.4 | ¥24.23 |
-7%
|
| 5-Year Average | 50.4 | ¥24.23 |
-7%
|
| Industry Average | 23.5 | ¥11.28 |
-57%
|
| Country Average | 26.4 | ¥12.69 |
-51%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Runben Biotechnology Co Ltd
SSE:603193
|
10.5B CNY | 54 | 34.4 | |
| US |
|
Kenvue Inc
NYSE:KVUE
|
33.4B USD | 26.8 | 22.7 | |
| KR |
A
|
APR Co Ltd
KRX:278470
|
15.9T KRW | 52.8 | 55.1 | |
| BR |
|
Natura &Co Holding SA
OTC:NTCOY
|
7.7B USD | 49 620.1 | -4.4 | |
| KY |
H
|
Herbalife Ltd
XMUN:HOO
|
4.5B EUR | -26.1 | 23.1 | |
| CN |
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
35.3B HKD | 47.4 | 25.6 | |
| KR |
d
|
d'Alba Global Co Ltd
KRX:483650
|
2.8T KRW | 41.8 | 35.4 | |
| IN |
H
|
Honasa Consumer Ltd
NSE:HONASA
|
110.8B INR | 144.8 | 71.2 | |
| ID |
|
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
|
14.7T IDR | 12.4 | 12 | |
| IL |
O
|
Oddity Tech Ltd
NASDAQ:ODD
|
846.4m USD | 1.3 | 7.6 | |
| CN |
D
|
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
|
5.5B CNY | 34.5 | 30.6 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 13.7 |
| Median | 26.4 |
| 70th Percentile | 52.8 |
| Max | 2 279 450.9 |
Other Multiples
Runben Biotechnology Co Ltd
Glance View
Runben Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of mosquito repellent, baby care products, and personal care products. The company is headquartered in Guangzhou, Guangdong and currently employs 917 full-time employees. The company went IPO on 2023-10-17. The firm's main products can be divided into three sectors: mosquito repellent products, baby care products and essential oil products. The firm's principal products include electric mosquito repellent liquid, DEET mosquito repellent liquid, lipstick, face cream, facial cleanser, skin care cream and others. The firm mainly provides products to consumers through Internet sales models such as online direct sales, online platform distribution, and online platform agency sales. The firm mainly conducts its businesses in the domestic market.
